Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

504 public trials 140 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Completed

A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia)

NCT04849416

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Wannan Medical College Yijishan Hospital Wuhu, Anhui, China
  • Beijing Cancer hospital Beijing, Beijing Municipality, China
  • Southern Medical University Nanfang Hospital Guangzhou, Guangdong, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View all 22 locations
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)

NCT03598608

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +9 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0020) Gilbert, Arizona, United States
  • City of Hope ( Site 0001) Duarte, California, United States
  • Ronald Reagan UCLA Medical Center (Radiological Sciences) ( Site 0007) Los Angeles, California, United States
  • Pacific Cancer Care ( Site 0006) Monterey, California, United States
View all 25 locations
View Trial Details
Completed

A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL

NCT03740529

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +35 more
Locations
  • Mayo Clinic of Scottsdale Scottsdale, Arizona, United States
  • Scripps Coastal Medical Center San Diego, California, United States
  • University of California San Francisco, Medical Center at Paranassus San Francisco, California, United States
  • Smilow Cancer Hospital at Yale-New Haven New Haven, Connecticut, United States
View all 56 locations
View Trial Details
Completed

BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I)

NCT04018248

Conditions
B Cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +36 more
Locations
  • Henry Ford Hospital Detroit, Michigan, United States
  • National Cancer Center Goyang-si, Gyeonggi-do, South Korea
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
  • Chonnam National University Hwasun Hospital Hwasun, Jeollanam-do, South Korea
View Trial Details

Related conditions